English

BioStock: Cereno reports positive data from patient case study

Report this content

Cereno Scientific has reported positive data received from a patient case study from the ongoing phase II trial with lead candidate CS1 in pulmonary arterial hypertension. The company’s CEO Sten R Sörensen passed by the BioStock Studio to comment on the significance of the results.

Watch the interview with CEO Sten R Sörensen at biostock.se

Cereno reports positive data from patient case study - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Subscribe

Documents & Links

Quick facts

BioStock: Cereno reports positive data from patient case study
Tweet this